Yield10 Bioscience Inc
NASDAQ:YTEN
Yield10 Bioscience Inc
Other Long-Term Assets
Yield10 Bioscience Inc
Other Long-Term Assets Peer Comparison
Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors
Company | Other Long-Term Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Yield10 Bioscience Inc
NASDAQ:YTEN
|
Other Long-Term Assets
$306k
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-8%
|
|
Abbvie Inc
NYSE:ABBV
|
Other Long-Term Assets
$9.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
51%
|
CAGR 10-Years
27%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Long-Term Assets
$4.8B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
14%
|
CAGR 10-Years
25%
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Long-Term Assets
$9B
|
CAGR 3-Years
16%
|
CAGR 5-Years
39%
|
CAGR 10-Years
19%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Long-Term Assets
$2.8B
|
CAGR 3-Years
49%
|
CAGR 5-Years
13%
|
CAGR 10-Years
75%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Long-Term Assets
$3.2B
|
CAGR 3-Years
55%
|
CAGR 5-Years
27%
|
CAGR 10-Years
29%
|
See Also
What is Yield10 Bioscience Inc's Other Long-Term Assets?
Other Long-Term Assets
306k
USD
Based on the financial report for Dec 31, 2023, Yield10 Bioscience Inc's Other Long-Term Assets amounts to 306k USD.
What is Yield10 Bioscience Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
-8%
Over the last year, the Other Long-Term Assets growth was 2%. The average annual Other Long-Term Assets growth rates for Yield10 Bioscience Inc have been -15% over the past three years , -5% over the past five years , and -8% over the past ten years .